4.5 Article

Modulation of HER3 Is a Marker of Dynamic Cell Signaling in Ovarian Cancer: Implications for Pertuzumab Sensitivity

期刊

MOLECULAR CANCER RESEARCH
卷 7, 期 9, 页码 1563-1571

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-09-0101

关键词

-

资金

  1. University of Tsukuba International Liaison [FY2007]
  2. Charon Fund
  3. Breakthrough Breast Cancer
  4. Scottish Funding Council

向作者/读者索取更多资源

This study was designed to evaluate the expression of HER receptors as a marker of sensitivity to the humanized anti-HER2 monoclonal antibody pertuzumab in ovarian cancer cells. In a recent clinical trial, low levels of HER3 mRNA have been shown to associate with pertuzumab response when combined with gemcitabine. We sought to define how pertuzumab modulated HER expression levels in ovarian cancer using cell line models to better understand differential and dynamic receptor expression in therapeutic response. Changes in HER3 mRNA expression were also assessed in pertuzumab-treated xenografts. HER3 mRNA and, to a lesser extent, HER2, were down-regulated after stimulation both with heregulin-beta 1 and epidermal growth factor in a range of ovarian cancer cell lines either growth sensitive or growth resistant to pertuzumab. Pertuzumab reversed this down-regulation and the magnitude of the reversal correlated with pertuzumab sensitivity. The change in HER3 mRNA expression correlated inversely to how much the extracellular signal-regulated kinase and phosphoinositide 3-kinase pathways were dynamically activated with stimulation. Finally, up-regulation of HER3 mRNA was found in cancer xenografts treated with pertuzumab. We conclude that HER3 mRNA is down-regulated by both heregulin-beta 1 and epidermal growth factor activation. This suggests that in some tumors, low HER3 mRNA expression is driven by, or dependent on, growth factor. HER3 mRNA expression is effectively reversed in pertuzumab-sensitive tumors. These data are consistent with low HER3 mRNA identifying a pertuzumab-sensitive phenotype. (Mol Cancer Res 2009;7(9):1563-71)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Public, Environmental & Occupational Health

Association between smoking, e-cigarette use and severe COVID-19: a cohort study

Min Gao, Paul Aveyard, Nicola Lindson, Jamie Hartmann-Boyce, Peter Watkinson, Duncan Young, Carol Coupland, Ashley K. Clift, David Harrison, Doug Gould, Ian D. Pavord, Margaret Smith, Julia Hippisley-Cox

Summary: Current smoking is associated with a lower risk of severe COVID-19 compared to never smokers, while former smokers have a higher risk. The association between e-cigarette use and severe COVID-19 is unclear.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Article Critical Care Medicine

Timing and burden of persistent critical illnessin UK intensive care units: An observational cohort study

David A. Harrison, Ben C. Creagh-Brown, Kathryn M. Rowan

Summary: Persistent critical illness is a common clinical syndrome in the ICU, which is associated with increased healthcare utilization and adverse outcomes. This study aimed to assess the predictive factors for survival in patients with persistent critical illness and compare the characteristics and outcomes of these patients with others. The findings suggest the need for improved understanding of long-term outcomes and the development of tools for prognostication.

JOURNAL OF THE INTENSIVE CARE SOCIETY (2023)

Article Critical Care Medicine

Critical illness related cardiac arrest: Protocol for an investigation of the incidence and outcome of cardiac arrest within intensive care units in the United Kingdom

Robert Darnell, Christopher Newell, Julia Edwards, Emma Gendall, David Harrison, Stefan Sprinckmoller, Paul Mouncey, Doug Gould, Matt Thomas

JOURNAL OF THE INTENSIVE CARE SOCIETY (2023)

Article Oncology

The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent

Jennifer Bre, Alison L. Dickson, Oliver J. Read, Ying Zhang, Fiona G. McKissock, Peter Mullen, Peijun Tang, Greice M. Zickuhr, Clarissa M. Czekster, David J. Harrison

Summary: NUC-3373 is a modified version of 5-fluorodeoxyuridine that shows higher anti-cancer activity and better safety profile compared to 5-FU, overcoming its limitations and pharmacologic challenges in clinical use.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2023)

Article Multidisciplinary Sciences

Detection of malignancy in whole slide images of endometrial cancer biopsies using artificial intelligence

Christina Fell, Mahnaz Mohammadi, David Morrison, Ognjen Arandjelovic, Sheeba Syed, Prakash Konanahalli, Sarah Bell, Gareth Bryson, David J. Harrison, David Harris-Birtill

Summary: In this study, AI was used to categorise endometrial biopsy whole slide images into malignant, other, benign, or insufficient categories. The digitalisation of pathology has led to the automation of image analysis, and a model that can classify slides in this way would help prioritise pathologists' workload and reduce diagnosis time for cancer patients. The final model achieved an accuracy of 90% in classifying slides correctly and 97% in the malignant class, demonstrating its effectiveness in assisting pathologists.

PLOS ONE (2023)

Article Oncology

The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I-Associated Peptides

Georges Bedran, Hans-Christof Gasser, Kenneth Weke, Tongjie Wang, Dominika Bedran, Alexander Laird, Christophe Battail, Fabio Massimo Zanzotto, Catia Pesquita, Hakan Axelson, Ajitha Rajan, David J. Harrison, Aleksander Palkowski, Maciej Pawlik, Maciej Parys, Robert O'Neill, Paul M. Brennan, Stefan N. Symeonides, David R. Goodlett, Kevin Litchfield, Robin Fahraeus, Ted R. Hupp, Sachin Kote, Javier A. Alfaro

Summary: Using deep learning mass spectrometry, we developed a proteogenomic pipeline to discover noncanonical MHC class I-associated peptides (ncMAP) from noncoding regions. Analyzing data from 26 MHC class I immunopeptidomic studies across 11 different cancer types, we identified an atlas of 8,601 ncMAPs and suggested 17 cancer-selective ncMAPs as attractive therapeutic targets.

CANCER IMMUNOLOGY RESEARCH (2023)

Article Computer Science, Information Systems

Whole-Slide Images and Patches of Clear Cell Renal Cell Carcinoma Tissue Sections Counterstained with Hoechst 33342, CD3, and CD8 Using Multiple Immunofluorescence

Georg Wolflein, In Hwa Um, David J. Harrison, Ognjen Arandjelovic

Summary: In recent years, efforts have been made to digitize whole-slide images of cancer tissue, providing new opportunities for deep learning in oncology. One promising application is virtual staining, where a deep learning model reproduces the appearance of stained tissue sections based on different input stains. However, there is a scarcity of supervised training data with aligned input and output stains on the same tissue sections. In this work, a dataset of ten whole-slide images of clear cell renal cell carcinoma tissue sections, along with over 600,000 patches and cell segmentation masks, is introduced to facilitate the development of deep learning methods for digital pathology and benchmark virtual staining models.
Article Biochemistry & Molecular Biology

Human 2 & PRIME;-Deoxynucleoside 5 & PRIME;-Phosphate N-Hydrolase 1: Mechanism of 2 & PRIME;-Deoxyuridine 5 & PRIME;-Monophosphate Hydrolysis

Suneeta Devi, Anna E. Carberry, Greice M. Zickuhr, Alison L. Dickson, David J. Harrison, Rafael G. da Silva

Summary: DNPH1 catalyzes the N-ribosidic bond cleavage of 5-hydroxymethyl-2'-deoxyuridine 5'-monophosphate to generate 2-deoxyribose 5-phosphate and 5-hydroxymethyluracil. The crystal structures of unliganded DNPH1 and DNPH1 bound with 2'-deoxyuridine 5'-monophosphate were solved, revealing the interaction between the catalytic Glu residue and a conserved Tyr residue. Functional data supported the proposed mechanism, with hydrolysis of dUMP confirmed by liquid chromatography-mass spectrometry analysis. The pH-rate profile and solvent isotope effects provided insights into the catalytic mechanism.

BIOCHEMISTRY (2023)

Article Cell Biology

Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage

Mustafa Elshani, In Hwa Um, Steve Leung, Paul A. Reynolds, Alex Chapman, Mary Kudsy, David J. Harrison

Summary: This study investigates the expression of NFE2L1 in podocytes and its correlation with kidney disease. The results show that NFE2L1 expression is decreased in renal diseases, and its nuclear expression is reduced under PAN treatment.
Article Computer Science, Artificial Intelligence

Impact of Different Mammography Systems on Artificial Intelligence Performance in Breast Cancer Screening

Clarisse F. de Vries, Samantha J. Colosimo, Roger T. Staff, Jaroslaw A. Dymiter, Joseph Yearsley, Deirdre Dinneen, Moragh Boyle, David J. Harrison, Lesley A. Anderson, Gerald Lip

Summary: Artificial intelligence (AI) tools may be helpful in breast screening mammography programs, but their generalizability to new settings should be validated. This study assessed the performance of a commercially available breast screening AI algorithm in a specific clinical site using a 3-year dataset. The algorithm's recall rates were high initially but reduced after threshold calibration and were influenced by software upgrades. Validating AI performance and thresholds in new clinical settings is important, and quality assurance systems should ensure consistency.

RADIOLOGY-ARTIFICIAL INTELLIGENCE (2023)

Proceedings Paper Computer Science, Artificial Intelligence

HoechstGAN: Virtual Lymphocyte Staining Using Generative Adversarial Networks

Georg Wolflein, In Hwa Um, David J. Harrison, Ognjen Arandjelovic

Summary: Understanding the presence and density of specific immune cell types is crucial for evaluating a patient's immune response to cancer. However, traditional immunofluorescence staining methods for identifying T cell subtypes are costly, time-consuming, and not commonly used in clinical settings. In this study, we propose a framework that utilizes generative adversarial networks to virtually stain Hoechst images with CD3 and CD8 markers, enabling the identification of T cell subtypes in clear cell renal cell carcinoma. By jointly learning both staining tasks, our method incorporates mutually beneficial information to improve accuracy. We also introduce a novel metric to evaluate the quality of virtual staining.

2023 IEEE/CVF WINTER CONFERENCE ON APPLICATIONS OF COMPUTER VISION (WACV) (2023)

暂无数据